September 27, 2022
A recent review article lists six other JAK inhibitors that might be used as treatments for vitiligo in addition to ruxolitinib, the active ingredient in recently approved Opzelura.
September 21, 2022
A national study in Germany identified the baseline characteristics of patients with moderate-to-severe atopic dermatitis (AD) to understand how they are usually treated with Dupixent in the real world.
September 14, 2022
Improvements in atopic dermatitis symptoms were seen in children taking dupilumab, with minimal adverse events.
August 31, 2022
Timber Pharmaceuticals’ CONTROL study evaluated the safety and efficacy of the topical isotretinoin.
August 30, 2022
New research examines how often immune-mediated inflammatory skin diseases occur in patients with inflammatory bowel disease.
August 25, 2022
Nonsteroidal topical agents and TYK2 inhibitors may join an already full armamentarium.
August 23, 2022
Improvement of vitiligo repigmentation in patients can result in higher Vitiligo Noticeability Scale values when assessed from patient-reported outcome measures versus traditional investigator-assessed studies.
August 19, 2022
Children with atopic dermatitis will soon have more options for treatment, as clinical trials show promising results.
August 18, 2022
Examining the results of a study examining the role of supplements and diets in managing psoriasis.
August 15, 2022
Results of methotrexate dosing for patients with psoriasis were published in the Journal of the American Medical Association Dermatology.
